Cargando…

2946. Comparative Pharmacokinetics and Pharmacodynamics of Cefadroxil and Cephalexin for Pediatric Musculoskeletal Infections

BACKGROUND: Methicillin-susceptible Staphylococcus aureus (MSSA) is one of the leading causes of pediatric musculoskeletal (MSK) infections, such as osteomyelitis and septic arthritis. MSSA MSK infections are treated initially with an IV antibiotic, followed by prolonged oral therapy. Cephalexin is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Haynes, Andrew, Wei, Zixuan, Anderson, Peter, Scheetz, Marc H, Parker, Sarah K, N, Douglas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679111/ http://dx.doi.org/10.1093/ofid/ofad500.185

Ejemplares similares

Cefadroxil Comparable to Cephalexin: Minimum Inhibitory Concentrations among Methicillin-Susceptible Staphylococcus aureus Isolates from Pediatric Musculoskeletal Infections
por: Haynes, Andrew S., et al.
Publicado: (2022)

1453. Cephalexin and Cefadroxil Are Not Therapeutic Equivalents for Uncomplicated Cystitis (uUTI): Further Analysis of Cefazolin Surrogate Susceptibility Testing Criteria
por: Jones, Ronald N, et al.
Publicado: (2019)

Potentiodynamic Poly(resorcinol)-Modified Glassy Carbon Electrode as a Voltammetric Sensor for Determining Cephalexin and Cefadroxil Simultaneously in Pharmaceutical Formulation and Biological Fluid Samples
por: Kassa, Adane, et al.
Publicado: (2022)

1506. Outcomes of Standardized Neonatal Cephalexin Dosing
por: Robertson, Melena J, et al.
Publicado: (2019)

1573. Population Pharmacokinetic Analyses for Cefepime in Adult and Pediatric Patients
por: Liu, Jiajun, et al.
Publicado: (2019)

A Systematic Review on the Clinical Pharmacokinetics of Cephalexin in Healthy and Diseased Populations
por: Kanan, Mohammed, et al.
Publicado: (2023)

Effect of Different Metal Ions on the Biological Properties of Cefadroxil
por: Auda, Sayed H., et al.
Publicado: (2009)

Effect of transporter inhibition on the distribution of cefadroxil in rat brain
por: Chen, Xiaomei, et al.
Publicado: (2014)

Simultaneous pharmacokinetic assessment of cefadroxil and clavulanic acid in human plasma by LC–MS and its application to bioequivalence studies
por: Nagarajan, Janaki Sankarachari Krishnan, et al.
Publicado: (2013)

Physiologically Based Pharmacokinetic Modeling of Cefadroxil in Mouse, Rat, and Human to Predict Concentration–Time Profile at Infected Tissue
por: Tan, Zhongxia, et al.
Publicado: (2021)

A Population Pharmacokinetic Approach to Describe Cephalexin Disposition in Adult and Aged Dogs
por: Prados, Ana Paula, et al.
Publicado: (2014)

973. Pharmacokinetic/Pharmacodynamic Evaluation and Dose Optimization of Daptomycin in Pediatric Patients with Staphylococcus aureus Bacteremia
por: Olney, Katie B, et al.
Publicado: (2023)

Cephalexin: clinical and laboratory studies.
por: Lyons, R. W., et al.
Publicado: (1971)

Cephalexin Induced Cholestatic Jaundice
por: Agrawal, Abhinav, et al.
Publicado: (2014)

Cephalexin-Induced Leukocytoclastic Vasculitis
por: Tang, Wesley, et al.
Publicado: (2022)

1321. Population Pharmacokinetic (PK) and Pharmacokinetic/Pharmacodynamic (PK/PD) Target Attainment Analyses for Dalbavancin in Pediatric Patients
por: Carrothers, Timothy J, et al.
Publicado: (2020)

The efficacy of retrograde intra-renal surgery (RIRS) for lower pole stones: results from 2946 patients
por: Giulioni, Carlo, et al.
Publicado: (2023)

Pharmacokinetics of Immediate and Sustained Release Cephalexin Administered by Different Routes to Llamas (Lama glama)
por: Kreil, Verónica, et al.
Publicado: (2016)

The effect of cephalexin in influencing the pharmacokinetics of a novel drug – 5′-valyl-cytarabine hydrochloride
por: Song, Xiaotong, et al.
Publicado: (2017)

Catecholamine pharmacokinetics and pharmacodynamics in critical illness
por: Johnston, AJ, et al.
Publicado: (2003)

Cephalexin-induced acute generalized exanthematous pustulosis
por: DaCunha, Matthew, et al.
Publicado: (2018)

Cefadroxil-Induced Clostridium difficile Infection Following Total Knee Arthroplasty
por: Angerett, Nathan, et al.
Publicado: (2022)

Diffuse Large B Cell Lymphoma Cell Line U-2946: Model for MCL1 Inhibitor Testing
por: Quentmeier, Hilmar, et al.
Publicado: (2016)

Risk modeling in transcatheter aortic valve replacement remains unsolved: an external validation study in 2946 German patients
por: Wolff, Georg, et al.
Publicado: (2020)

278. Comparison of Oral Cephalexin Versus Oral Levofloxacin for Treatment of Uncomplicated Enterobacterales Bacteremia
por: Leung, Thomas H, et al.
Publicado: (2020)

Comparative effects of systemic administration of levofloxacin and cephalexin on fracture healing in rats
por: Golestani, Shayan, et al.
Publicado: (2022)

1568. The Pharmacodynamic–Toxicodynamic Relationship of AUC and CMAX in Vancomycin-Induced Kidney Injury
por: Avedissian, Sean N, et al.
Publicado: (2019)

Stevens–Johnson syndrome/toxic epidermal necrolysis caused by cefadroxil in a cat
por: Sartori, Roberta, et al.
Publicado: (2016)

Penicillin and cephalosporin cross-reactivity: role of side chain and synthetic cefadroxil epitopes
por: Bogas, Gador, et al.
Publicado: (2020)

Pharmacokinetics and pharmacodynamics of natalizumab in pediatric patients with RRMS
por: Ghezzi, Angelo, et al.
Publicado: (2019)

Evaluation of Pharmacokinetics and Pharmacodynamics of Deferasirox in Pediatric Patients
por: Galeotti, Laura, et al.
Publicado: (2021)

Pharmacokinetic–Pharmacodynamic Modeling of Midazolam in Pediatric Surgery
por: Flores-Pérez, Carmen, et al.
Publicado: (2023)

LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baumannii-calcoaceticus Complex (ABC) Infections
por: Bhavnani, Sujata M, et al.
Publicado: (2022)

1535. Pharmacokinetic (PK) and Pharmacodynamic (PD) Evaluation of Cefepime (CPM) in Obese and Non-Obese Patients
por: Morrisette, Taylor, et al.
Publicado: (2019)

2845. Two Times versus Four Times Daily Cephalexin Dosing for the Treatment of Uncomplicated Urinary Tract Infection in Females
por: Yetsko, Aidan, et al.
Publicado: (2023)

1567. Pharmacokinetic/Pharmacodynamic Target Attainment in Adult and Pediatric Patients following Administration of Ceftaroline Fosamil as a 5-Minute Infusion
por: Riccobene, Todd, et al.
Publicado: (2019)

The Pharmacokinetic and Pharmacodynamic Properties of Hydroxychloroquine and Dose Selection for COVID-19: Putting the Cart Before the Horse
por: Morrisette, Taylor, et al.
Publicado: (2020)

812. The Impact of Post-Operative Cephalexin on Surgical Site (SSI) Infections During a Cefazolin Shortage
por: Brown, Sara, et al.
Publicado: (2021)

1547. Modeling Pharmacokinetics and Pharmacodynamics of Meropenem Utilizing a Novel Infusion Method of Bolus to Prolonged Infusion
por: Moore, Sarah E, et al.
Publicado: (2019)

2564. Population Pharmacokinetics and Pharmacodynamics of Cefepime in Hospitalized Obese and Non-Obese Patients
por: Shin, Beomjin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8tb4c9jm1tskpsikp32u973h9g